Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017
Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital   Conference Call to Review Results to be Held Thursday, November 16, 2017 LYON, France , November 01, 2017 - EDAP TMS SA
View HTML
Toggle Summary EDAP TMS to Present at Rodman and Renshaw Global Investment Conference
LYON, France , Sept. 2, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer of EDAP TMS is scheduled to present at the 17 th Annual Rodman & Renshaw Global Investment conference being held
View HTML
Toggle Summary EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
LYON, France , Sept. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA  (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer of EDAP TMS , is scheduled to present at the 18 th Annual Rodman & Renshaw Global Investment Conference being
View HTML
Toggle Summary EDAP TMS to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
LYON, France , August 24, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer, will present at the 19 th Annual Rodman & Renshaw Global Investment Conference to be held September 10-12, 2017
View HTML
Toggle Summary Edap Tms: EDAP Announces Positive Outcome from CPT Panel for HIFU Reimbursement in the U.S.
AMA allocates a new Category 1 CPT code for High Intensity Focused Ultrasound (HIFU)   Definitive CPT code will cover the transrectal ablation of malignant prostate tissue with HIFU including ultrasound guidance LYON, France , June 10, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”) , the global
View HTML
Toggle Summary EDAP to Add University of Colorado Under Direction of Dr. David Crawford to Clinical Study
EDAP to Add University of Colorado Under Direction of Dr. David Crawford to Clinical Study LYON, France , June 5 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, intends to add the University of
View HTML
Toggle Summary EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023  
- Company to host conference call and webcast on Wednesday, May 1 7 th at 8:30 am EDT - LYON, France, May 3, 2023 - EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended
View HTML
Toggle Summary EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
LYON, France, March 9, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full-year ended December 31, 2022, before the markets open on Thursday, March 30 th ,
View HTML
Toggle Summary EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
Company to host conference call and webcast on Wednesday, March 27 th at 8:30am EDT LYON, France, March 13, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and
View HTML
Toggle Summary EDAP to Collaborate On Research Program for Cancer Treatment
Joint Cooperation With Epitarget AS and INSERM to Improve Delivery of Cancer Drugs With HIFU
View HTML